[go: up one dir, main page]

NO990814L - Chemical connections - Google Patents

Chemical connections

Info

Publication number
NO990814L
NO990814L NO990814A NO990814A NO990814L NO 990814 L NO990814 L NO 990814L NO 990814 A NO990814 A NO 990814A NO 990814 A NO990814 A NO 990814A NO 990814 L NO990814 L NO 990814L
Authority
NO
Norway
Prior art keywords
chemical connections
connections
chemical
Prior art date
Application number
NO990814A
Other languages
Norwegian (no)
Other versions
NO309305B1 (en
NO990814D0 (en
Inventor
Bernt Boerretzen
Vidar Moen
Rolf Olaf Larsen
Erik Olai Pettersen
Camilla Bruno Dunsaed
Geir Sagvolden
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Priority to NO990814A priority Critical patent/NO309305B1/en
Publication of NO990814D0 publication Critical patent/NO990814D0/en
Priority to IL14489600A priority patent/IL144896A0/en
Priority to EP00906782A priority patent/EP1150690A1/en
Priority to RU2001123124/15A priority patent/RU2001123124A/en
Priority to RU2001123035/14A priority patent/RU2001123035A/en
Priority to AU28341/00A priority patent/AU2834100A/en
Priority to AU28342/00A priority patent/AU2834200A/en
Priority to MXPA01008346A priority patent/MXPA01008346A/en
Priority to JP2000599400A priority patent/JP2002537263A/en
Priority to MXPA01008347A priority patent/MXPA01008347A/en
Priority to CA002362306A priority patent/CA2362306A1/en
Priority to PCT/NO2000/000059 priority patent/WO2000048609A1/en
Priority to SK1161-2001A priority patent/SK11612001A3/en
Priority to EP00906781A priority patent/EP1150689A1/en
Priority to PL00350520A priority patent/PL350520A1/en
Priority to SK1160-2001A priority patent/SK11602001A3/en
Priority to JP2000599401A priority patent/JP2002537264A/en
Priority to CN00806488A priority patent/CN1347323A/en
Priority to CN00806338A priority patent/CN1347322A/en
Priority to CZ20012965A priority patent/CZ20012965A3/en
Priority to HU0105281A priority patent/HUP0105281A2/en
Priority to IL14489500A priority patent/IL144895A0/en
Priority to CZ20012966A priority patent/CZ20012966A3/en
Priority to PCT/NO2000/000060 priority patent/WO2000048610A1/en
Priority to PL00350519A priority patent/PL350519A1/en
Priority to CA002363670A priority patent/CA2363670A1/en
Priority to BR0008302-0A priority patent/BR0008302A/en
Priority to BR0008297-0A priority patent/BR0008297A/en
Priority to HU0105280A priority patent/HUP0105280A2/en
Publication of NO990814L publication Critical patent/NO990814L/en
Publication of NO309305B1 publication Critical patent/NO309305B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO990814A 1999-02-19 1999-02-19 Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives NO309305B1 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
NO990814A NO309305B1 (en) 1999-02-19 1999-02-19 Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives
HU0105280A HUP0105280A2 (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives and their pharmaceutical use and medicaments containing the compounds
PL00350520A PL350520A1 (en) 1999-02-19 2000-02-18 Chemical compounds
SK1160-2001A SK11602001A3 (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives useful as anticancer agents
RU2001123124/15A RU2001123124A (en) 1999-02-19 2000-02-18 Chemical compounds
RU2001123035/14A RU2001123035A (en) 1999-02-19 2000-02-18 CHEMICAL COMPOUNDS
AU28341/00A AU2834100A (en) 1999-02-19 2000-02-18 Chemical compounds
AU28342/00A AU2834200A (en) 1999-02-19 2000-02-18 Chemical compounds
MXPA01008346A MXPA01008346A (en) 1999-02-19 2000-02-18 Chemical compounds.
JP2000599400A JP2002537263A (en) 1999-02-19 2000-02-18 Chemical substances
MXPA01008347A MXPA01008347A (en) 1999-02-19 2000-02-18 Chemical compounds.
CA002362306A CA2362306A1 (en) 1999-02-19 2000-02-18 Chemical compounds
PCT/NO2000/000059 WO2000048609A1 (en) 1999-02-19 2000-02-18 Chemical compounds
SK1161-2001A SK11612001A3 (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives useful as anticancer agents
EP00906781A EP1150689A1 (en) 1999-02-19 2000-02-18 Chemical compounds
IL14489600A IL144896A0 (en) 1999-02-19 2000-02-18 Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds
JP2000599401A JP2002537264A (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives
IL14489500A IL144895A0 (en) 1999-02-19 2000-02-18 Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds
PCT/NO2000/000060 WO2000048610A1 (en) 1999-02-19 2000-02-18 Chemical compounds
CN00806338A CN1347322A (en) 1999-02-19 2000-02-18 Chemical compounds
CZ20012965A CZ20012965A3 (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives that are suitable for use as antitumor preparations
HU0105281A HUP0105281A2 (en) 1999-02-19 2000-02-18 Anticancer benzaldehyde derivatives and their pharmaceutical use
EP00906782A EP1150690A1 (en) 1999-02-19 2000-02-18 Chemical compounds
CZ20012966A CZ20012966A3 (en) 1999-02-19 2000-02-18 Benzaldehyde derivatives that are suitable for use as antitumor preparations
CN00806488A CN1347323A (en) 1999-02-19 2000-02-18 Chemical compounds
PL00350519A PL350519A1 (en) 1999-02-19 2000-02-18 Chemical compounds
CA002363670A CA2363670A1 (en) 1999-02-19 2000-02-18 Chemical compounds
BR0008302-0A BR0008302A (en) 1999-02-19 2000-02-18 Use of a benzaldehyde derivative, benzaldehyde derivative, pharmaceutical composition, and process for manufacturing it
BR0008297-0A BR0008297A (en) 1999-02-19 2000-02-18 Use of 4,6-o- (benzylidene-d1) -d-glucopyranose, 4,6-o-benzylidene-1-glucopyranose, and / or 4,6-o- (benzylidene-d1) -l-glucopyranose, or an acceptable pharmaceutical salt thereof, derived from benzaldehyde pharmaceutical composition, and process for the manufacture thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO990814A NO309305B1 (en) 1999-02-19 1999-02-19 Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives

Publications (3)

Publication Number Publication Date
NO990814D0 NO990814D0 (en) 1999-02-19
NO990814L true NO990814L (en) 2000-08-21
NO309305B1 NO309305B1 (en) 2001-01-15

Family

ID=19902986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990814A NO309305B1 (en) 1999-02-19 1999-02-19 Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives

Country Status (15)

Country Link
EP (2) EP1150690A1 (en)
JP (2) JP2002537263A (en)
CN (2) CN1347323A (en)
AU (2) AU2834100A (en)
BR (2) BR0008302A (en)
CA (2) CA2363670A1 (en)
CZ (2) CZ20012966A3 (en)
HU (2) HUP0105280A2 (en)
IL (2) IL144895A0 (en)
MX (2) MXPA01008346A (en)
NO (1) NO309305B1 (en)
PL (2) PL350520A1 (en)
RU (2) RU2001123035A (en)
SK (2) SK11602001A3 (en)
WO (2) WO2000048610A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4182218B2 (en) * 2001-05-30 2008-11-19 学校法人東京理科大学 Novel glucose derivative that induces apoptosis, process for its production and its use as a medicament
DE10261807A1 (en) * 2002-12-19 2004-07-01 Turicum Drug Development Ag Deuterated catecholamine derivatives and medicinal products containing these compounds
NZ565078A (en) * 2005-07-26 2010-03-26 Nycomed Gmbh Deuterated proton pump inhibitors such as omeprazole
EP1912947A1 (en) * 2005-07-26 2008-04-23 Nycomed GmbH Isotopically substituted pantoprazole
JP2009511481A (en) * 2005-10-06 2009-03-19 オースペックス・ファーマシューティカルズ・インコーポレイテッド Gastric H +, K + -ATPase deuteration inhibitors with enhanced therapeutic properties
CN101157711B (en) * 2007-09-28 2010-12-08 西安交通大学 A compound with antitumor activity and its use
JP2011516478A (en) * 2008-04-03 2011-05-26 コグネイト ３，エルエルシー Compositions and methods for immunotherapy
CN101735284B (en) * 2008-11-24 2012-05-23 上海医药工业研究院 Preparation method of 4, 6-O-benzylidene-D-glucopyranose
PL3076967T3 (en) 2013-12-03 2021-12-20 Intra-Cellular Therapies, Inc. METHODS OF TREATMENT OF RESIDUAL SYMPTOMS OF SCHIZOPHRENIA
MX388258B (en) 2014-04-04 2025-03-19 Intra Cellular Therapies Inc Organic compounds
JP6898072B2 (en) * 2015-08-27 2021-07-07 秀行 佐谷 14-3-3 Protein activity regulator
PL3407889T3 (en) 2016-03-25 2021-11-22 Intra-Cellular Therapies, Inc. Organic compounds and their use in treating or preventing central nervous system disorders
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
KR20240141212A (en) 2017-03-24 2024-09-25 인트라-셀룰라 써래피스, 인코퍼레이티드. Novel compositions and methods
EP3843729A4 (en) 2018-08-29 2022-06-01 Intra-Cellular Therapies, Inc. Novel compositions and methods
CN118873536A (en) 2018-08-31 2024-11-01 细胞内治疗公司 New approach
WO2020047407A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
EP4134101A1 (en) 2019-07-07 2023-02-15 Intra-Cellular Therapies, Inc. Deuterated lumateperone for the treatment of the bipolar ii disorder
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB811510A (en) * 1954-12-20 1959-04-08 Gyogyszeripari Ki New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof
JPS6112623A (en) * 1984-06-28 1986-01-21 Kaken Pharmaceut Co Ltd enkephalinase inhibitor
JPS6256423A (en) * 1985-09-06 1987-03-12 Kaken Pharmaceut Co Ltd Remedy and ameliorating agent for cachexia
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
JPH07145191A (en) * 1993-11-24 1995-06-06 Japan Tobacco Inc Galactosyl phosphonate derivative

Also Published As

Publication number Publication date
BR0008297A (en) 2002-05-28
WO2000048610A1 (en) 2000-08-24
PL350520A1 (en) 2002-12-16
CA2363670A1 (en) 2000-08-24
JP2002537264A (en) 2002-11-05
EP1150690A1 (en) 2001-11-07
SK11602001A3 (en) 2002-02-05
RU2001123035A (en) 2004-03-20
HUP0105280A2 (en) 2002-04-29
HUP0105281A2 (en) 2002-05-29
BR0008302A (en) 2002-08-27
CN1347322A (en) 2002-05-01
AU2834100A (en) 2000-09-04
CA2362306A1 (en) 2000-08-24
AU2834200A (en) 2000-09-04
IL144896A0 (en) 2002-06-30
NO309305B1 (en) 2001-01-15
EP1150689A1 (en) 2001-11-07
CN1347323A (en) 2002-05-01
SK11612001A3 (en) 2002-04-04
JP2002537263A (en) 2002-11-05
IL144895A0 (en) 2002-06-30
PL350519A1 (en) 2002-12-16
MXPA01008347A (en) 2004-03-10
CZ20012965A3 (en) 2002-03-13
NO990814D0 (en) 1999-02-19
WO2000048609A1 (en) 2000-08-24
RU2001123124A (en) 2004-02-20
MXPA01008346A (en) 2003-06-06
CZ20012966A3 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
NO20020765L (en) Chemical connections
NO20021637D0 (en) Chemical connections
NO20006152D0 (en) Chemical connections
NO20032829L (en) Chemical connections
NO20024774D0 (en) Chemical connections
NO20031561D0 (en) Chemical connections
NO2010019I2 (en) 6-per-deoxy-6-per- (2-karboksetyl) thio-y-cyclodextrin
NO20002359D0 (en) Chemical connections
NO20002360D0 (en) Chemical connections
NO20002361D0 (en) Chemical connections
DE10084676T1 (en) Einmallanzettvorrichtung
ATA51899A (en) handstamp
ATE357433T1 (en) 4-PYRIMIDINYL-N-ACYL-L-PHENYLANINE
FI4231U1 (en) CASE
NO20030628D0 (en) Chemical connections
NO990814L (en) Chemical connections
DE60024400D1 (en) receiving set
NO20021815L (en) Connection
FI19992274L (en) Connection
ATE440824T1 (en) NITRO-SULFOBENSAMIDE
DE10082008D2 (en) Ausbeulgerät
NO993313D0 (en) Chemical connections
ATA107599A (en) HEIZWASSERBEREITER
NO20020672L (en) Bredbåndpolarisasjonsfilter
NO20001448L (en) Chemical connections

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2003